Bextra Withdrawal Could Be Just the Beginning for Pfizer


The pharmaceutical industry is a tremendously profitable one, as anyone who reads the business pages of their newspaper can see. Although it can take years to develop a new drug and bring it to market, the profits obtained from a breakthrough drug can be staggering. Last year Merck sold about $2.5 billion worth of Vioxx, and Pfizer sold about $1.3 billion worth of Bextra. The profits are huge, but so are the losses if a problem should develop with a pharmaceutical product. Pfizer voluntarily withdrew the popular anti-inflammatory drug Bextra from the market last month, and their stock has suffered from both the loss of sales and the potential for a large number of product liability lawsuits. Pfizer may have to endure a double whammy this year as the FDA announced that they are investigating reports that the impotence drug Viagra may be linked to cases of blindness in male users. Cialis and Levitra were also mentioned in the report, although most of the cases involved the use of Viagra.

The FDA reports shouldn't cause alarm; the agency says that it is investigating fewer than 50 incidents of blindness in patients who use a drug that has been used by more than twenty million people since its introduction seven years ago. The FDA investigation says less about the likelihood of blindness in patients than it does about the agency's own concerns about its reputation. The FDA rightly insists upon rigorous testing of drugs before they reach the market in the name of public safety. But that coin has two sides, and there are those who say that the agency is too quick to approve potentially dangerous drugs and others who say that the agency's testing isn't thorough enough. Adding fuel to the fire are the recent memos obtained from Merck employees that suggest that the company was aggressively marketing Vioxx even though their sales staff knew the drug was potentially dangerous.

There may be no link between Viagra and blindness at all, as the form of sudden blindness alleged to have been caused by Viagra use is common to the sorts of patients who have erectile disfunction. The FDA is just being cautious, as they should be. Further tests will determine if there is an actual link. The party likely to suffer immediately is Pfizer, as stockholders, already concerned about Bextra lawsuits, drove the stock price lower immediately upon the release of the Viagra news. Sales will probably decrease, too, as patients who are now accustomed to reading about drugs being withdrawn from the market may shy away from the product until further tests are done. That could present a huge income for Pfizer, as they currently sell about $2 billion worth of Viagra each year. The drug business is a profitable one, but like any business, comes with risks. This year, it would seem that Pfizer is getting a double dose of bad medicine.

©Copyright 2005 by Retro Marketing. Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.







Related News



Spirituality, Evidence-Based Medicine, and Alcoholics Anonymous - Am J Psychiatry (subscription)

Spirituality, Evidence-Based Medicine, and Alcoholics Anonymous
Am J Psychiatry (subscription) -7 hours ago
For example, Alcoholics Anonymous (AA), a self-designated "spiritual fellowship," is a useful adjunct to the practice of evidence-based addiction medicine. ...

Pediatricians and the Promotion and Support of Breastfeeding - Archives of Pediatrics

Pediatricians and the Promotion and Support of Breastfeeding
Archives of Pediatrics -4 hours ago
Author Affiliations: Division of Adolescent Medicine, Department of Pediatrics, Cooper University Hospital, University of Medicine and Dentistry of New ...
Adult medicine enters the medical homeAAP News (subscription)
all 2 news articles

New Marketing Coaching and Consulting Firm for Physicians ... - MarketWatch

New Marketing Coaching and Consulting Firm for Physicians ...
MarketWatch -9 hours ago
"There are a growing number of physicians making the switch to concierge medicine, but they either don't know how to effectively convert their existing ...

Cardiologists Debate Expensive Heart Scans - New York Times

Cardiologists Debate Expensive Heart Scans
New York Times, United States -7 hours ago
In the latest study, published last week in The New England Journal of Medicine, researchers assessed the accuracy of CT angiography in identifying ...
Heading off heart attacks in womenChicago Daily Herald
all 3 news articles


Effort in Senegal to Join Traditional & Conventional Medicine - Voice of America

Voice of America

Effort in Senegal to Join Traditional & Conventional Medicine
Voice of America -9 hours ago
By Scott Bobb Traditional medicine was once thought of as sorcery or quackery. But the craft is slowly gaining the respect of conventional medical ...
Modern West African Market Offers Traditional Remedies for IllnessVoice of America
all 2 news articles

Three FAAPs elected to Institute of Medicine - AAP News (subscription)

Three FAAPs elected to Institute of Medicine
AAP News (subscription) -7 hours ago
Three AAP Fellows were among 65 new members elected to the Institute of Medicine, one of the highest honors in the fields of health and medicine that ...
FELLOWS IN THE NEWSAAP News (subscription)
Lake Tahoe hosts Practical Pediatrics, offers range of seminarsAAP News (subscription)
all 3 news articles

Most Patients Should Be Screened for HIV, Physicians’ Group Says - New York Times

TheMedGuru

Most Patients Should Be Screened for HIV, Physicians’ Group Says
New York Times, United States -3 hours ago
Just 50 to 100 of the nation’s 5000 emergency rooms routinely test for HIV, said Dr. Richard Rothman, associate professor of emergency medicine at Johns ...
World AIDS Day Calls For HIV TestingeMaxHealth.com
Doctors: Test All Patients Over 13 for HIVWebMD
Guideline Urges HIV Tests for All Patients 13 and OlderWashington Post
MedPage Today - MarketWatch
all 56 news articles

China Medicine Corporation Awarded GSP Certification - MarketWatch

China Medicine Corporation Awarded GSP Certification
MarketWatch -10 hours ago
("China Medicine" or "the Company"), a leading developer and distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines...

Organogenesis Receives Two Prestigious Awards for Economic Impact ... - MarketWatch

Organogenesis Receives Two Prestigious Awards for Economic Impact ...
MarketWatch -7 hours ago
Organogenesis was the first company to successfully mass produce living regenerative medicine products -- reaching hundreds of thousands of patients in the ...

FDA continues gathering information on cough medicine use in children - AAP News (subscription)

FDA continues gathering information on cough medicine use in children
AAP News (subscription) -7 hours ago
Cough and cold products are among the most widely used medicines in children. These drugs, which treat symptoms not the underlying disease, fall into four ...